Company Number: 14032383

Analysis Date: 2025-07-20 17:00 UTC

1. Credit Opinion: APPROVE
   LSC Therapy Limited, a micro-entity incorporated in 2022, demonstrates a stable and improving financial position with positive net assets and working capital. The company is active with no overdue filings, indicating good compliance and governance. Given the small scale and consistent net asset growth, the company shows capability to meet short-term liabilities and service modest credit facilities. However, the limited operational scale and single employee suggest credit limits should remain conservative, suitable for small, short-term financing needs.

2. Financial Strength:
   The balance sheet as of 30 April 2024 shows net assets of £9,441, up from £7,929 the previous year, reflecting growth in both fixed and current assets. Fixed assets are minimal (£2,117), consistent with a service business model, and current assets exceed current liabilities by £7,324, demonstrating positive working capital. The shareholders' funds mirror net assets, evidencing no reliance on external equity or debt. The micro-entity status limits the complexity and scale, but the financial position is sound for its size.

3. Cash Flow Assessment:
   Current assets largely represent cash or equivalents and receivables, sufficient to cover current liabilities of £11,526. The net current asset position of £7,324 provides a reasonable liquidity buffer. The absence of audit and limited disclosures restrict detailed cash flow insight, but the positive working capital and no overdue payments suggest adequate liquidity to manage day-to-day operations and short-term credit obligations.

4. Monitoring Points:

• Continued compliance with filing deadlines to avoid penalties and maintain creditor confidence.
• Monitor growth in current liabilities relative to current assets to ensure liquidity remains positive.
• Watch for any operational changes that increase employee count or fixed assets, which may affect credit risk.
• Assess the impact of economic conditions on the niche therapy services market and client payment behavior.
• Maintain vigilance on directors’ conduct and any PSC changes.